RTTNews | Sep 21, 2021 08:57AM EDT

08:57 Tuesday, September 21, 2021 (RTTNews.com) - Biopharmaceutical company Gossamer Bio, Inc. (GOSS) announced Tuesday that Bryan Giraudo has been appointed Chief Operating Officer, in addition to his continued role as Chief Financial Officer. Giraudo joined Gossamer in May 2018 as its Chief Financial Officer.

Prior to joining Gossamer Bio, Giraudo was a Senior Managing Director at Leerink Partners, now known as SVB Leerink, from 2009 to April 2018. Before joining Leerink, Giraudo was a Managing Director in Merrill Lynch's Global Healthcare Investment Banking Group.

Read the original article on RTTNews ( https://www.rttnews.com/3227171/gossamer-bio-appoints-cfo-bryan-giraudo-to-addl-role-of-coo-quick-facts.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved